• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[上尿路和下尿路尿路上皮癌——哪些危险因素使得早期检测具有价值?]

[Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?].

作者信息

Westhoff Niklas, Rieger Constantin, Heidenreich Axel, Bolenz Christian, Michel Maurice Stephan

机构信息

Klinik für Urologie und Urochirurgie, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.

Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Köln, Deutschland.

出版信息

Urologie. 2025 Jan;64(1):4-13. doi: 10.1007/s00120-024-02479-0. Epub 2024 Nov 26.

DOI:10.1007/s00120-024-02479-0
PMID:39589482
Abstract

Urothelial carcinoma is one of the most common malignancies both in Germany and worldwide. Due to the frequent occurrence of late-onset or nonspecific symptoms, carcinomas are often diagnosed at advanced stages. Structured early detection programs have the potential to detect urothelial carcinoma in earlier stages and to improve survival rates. Various risk factors are associated with urothelial carcinoma, most notably tobacco abuse and occupational exposure, as well as genetic disorders such as Lynch syndrome in upper urinary tract carcinoma. In clinical practice, diagnostic tools include general examinations and ultrasound imaging of the urinary tract, with microhematuria and urine cytology playing key roles. For screening purposes noninvasive urine markers have demonstrated limited evidence. Despite the lack of optimal diagnostic markers for systematic early detection in high-risk populations, it is essential to ensure that every patient presenting with hematuria undergoes appropriate and risk-adapted diagnostics.

摘要

尿路上皮癌是德国和全球最常见的恶性肿瘤之一。由于晚期发病或非特异性症状频繁出现,尿路上皮癌往往在晚期才被诊断出来。结构化的早期检测项目有潜力在更早期阶段检测出尿路上皮癌,并提高生存率。多种风险因素与尿路上皮癌相关,最显著的是烟草滥用和职业暴露,以及上尿路癌中的林奇综合征等遗传疾病。在临床实践中,诊断工具包括全身检查和泌尿系统超声成像,其中微量血尿和尿液细胞学检查起着关键作用。对于筛查目的而言,非侵入性尿液标志物的证据有限。尽管缺乏用于高危人群系统早期检测的最佳诊断标志物,但确保每一位出现血尿的患者都接受适当且根据风险调整的诊断至关重要。

相似文献

1
[Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?].[上尿路和下尿路尿路上皮癌——哪些危险因素使得早期检测具有价值?]
Urologie. 2025 Jan;64(1):4-13. doi: 10.1007/s00120-024-02479-0. Epub 2024 Nov 26.
2
Microscopic hematuria as a screening marker for urinary tract malignancies.镜下血尿作为尿路恶性肿瘤的筛查标志物。
Int J Urol. 2001 Jan;8(1):1-5. doi: 10.1046/j.1442-2042.2001.00235.x.
3
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
4
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.在全面筛查中DNA错配修复蛋白免疫组化表达缺失的上尿路尿路上皮癌患者的临床病理特征
Int J Urol. 2018 Feb;25(2):151-156. doi: 10.1111/iju.13481. Epub 2017 Nov 22.
5
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.一项多机构数据库分析显示,一部分遗传性上尿路尿路上皮癌根据分类被误诊为散发性:提出患者特异性风险识别工具。
BJU Int. 2012 Dec;110(11 Pt B):E583-9. doi: 10.1111/j.1464-410X.2012.11298.x. Epub 2012 Jun 15.
6
Using Hematuria as Detection of Post-kidney Transplantation Upper Urinary Tract Urothelial Carcinoma Is Associated With Delayed Diagnosis of Cancer Occurrence.将血尿作为肾移植后上尿路尿路上皮癌的检测方法与癌症发生的延迟诊断相关。
Transplant Proc. 2017 Jun;49(5):1061-1063. doi: 10.1016/j.transproceed.2017.03.070.
7
[Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].[上尿路尿路上皮癌的临床、输尿管镜及光动力诊断:法国国家泌尿外科学会年度科学报告的最新综述]
Prog Urol. 2014 Nov;24(15):977-86. doi: 10.1016/j.purol.2014.07.012. Epub 2014 Sep 8.
8
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome.基于尿分析的林奇综合征患者尿路上皮癌筛查评估。
Dis Colon Rectum. 2022 Jan 1;65(1):40-45. doi: 10.1097/DCR.0000000000002062.
9
Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract.评估尿细胞学阳性而尿路无明显疾病的女性。
Urology. 2023 Mar;173:10-16. doi: 10.1016/j.urology.2022.12.032. Epub 2023 Jan 6.
10
Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?尿液标志物对上尿路尿路上皮癌检测的性能:上尿路尿液比膀胱尿液更准确吗?
Dis Markers. 2018 Jan 30;2018:5823870. doi: 10.1155/2018/5823870. eCollection 2018.

本文引用的文献

1
Risk factors for secondary bladder cancer following prostate cancer radiotherapy.前列腺癌放疗后继发性膀胱癌的危险因素。
Transl Androl Urol. 2024 Jul 31;13(7):1288-1296. doi: 10.21037/tau-23-667. Epub 2024 Jun 17.
2
[Lynch syndrome].[林奇综合征]
Pathologie (Heidelb). 2024 Jul;45(4):290-299. doi: 10.1007/s00292-024-01339-0. Epub 2024 Jun 12.
3
Risk of Secondary Malignancies After Pelvic Radiation: A Population-based Analysis.盆腔放疗后发生继发性恶性肿瘤的风险:一项基于人群的分析。
Eur Urol Open Sci. 2024 Mar 23;63:52-61. doi: 10.1016/j.euros.2024.02.013. eCollection 2024 May.
4
Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the SEER database.SEER数据库中前列腺癌外照射放疗后继发性恶性肿瘤的发病率和生存率。
Can Urol Assoc J. 2024 Apr;18(4):121-128. doi: 10.5489/cuaj.8508.
5
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.BTA stat®、NMP22® BladderChek®、UBC®快速检测以及CancerCheck® UBC®快速可视化检测作为膀胱癌尿液标志物:一项德国多中心研究的最终结果。
Urol Oncol. 2023 Dec;41(12):484.e17-484.e26. doi: 10.1016/j.urolonc.2023.06.013. Epub 2023 Jul 4.
6
Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults.纵向体重指数与癌症风险:260 万加泰罗尼亚成年人的队列研究。
Nat Commun. 2023 Jun 30;14(1):3816. doi: 10.1038/s41467-023-39282-y.
7
Urine biomarkers in bladder cancer - current status and future perspectives.膀胱癌中的尿液生物标志物——现状与未来展望
Nat Rev Urol. 2023 Oct;20(10):597-614. doi: 10.1038/s41585-023-00773-8. Epub 2023 May 24.
8
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.全基因组关联研究揭示膀胱癌新的生物学和转化研究见解。
Eur Urol. 2023 Jul;84(1):127-137. doi: 10.1016/j.eururo.2023.04.020. Epub 2023 May 19.
9
PET in bladder cancer imaging.正电子发射断层扫描(PET)在膀胱癌成像中的应用。
Curr Opin Urol. 2023 May 1;33(3):206-210. doi: 10.1097/MOU.0000000000001090. Epub 2023 Mar 6.
10
VI-RADS in bladder cancer: Overview, pearls and pitfalls.膀胱癌 VI-RADS:概述、要点及陷阱。
Eur J Radiol. 2023 Mar;160:110666. doi: 10.1016/j.ejrad.2022.110666. Epub 2023 Jan 2.